# Ophthalmic Solution in Diabetic Corneal Alteration

> **NCT06573606** · — · COMPLETED · sponsor: **D&V FARMA srl** · enrollment: 20 (actual)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DEVICE:** CX-HA and CS

## Key facts

- **NCT ID:** NCT06573606
- **Lead sponsor:** D&V FARMA srl
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06573606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06573606, "Ophthalmic Solution in Diabetic Corneal Alteration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06573606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*